Oxford Covid vaccine 70% effective
November 23, 2020  13:35
image
AstraZeneca says late-stage trials of its COVID-19 vaccine were "highly effective'' in preventing disease. A vaccine developed by AstraZeneca and the University of Oxford prevented 70% of people from developing the coronavirus in late-stage trials, the team reported Monday. Researchers found that if people were given a half dose followed by a full dose, rather than two full doses, protection rose to about 90%. These findings show that we have an effective vaccine that will save many lives. Two other drugmakers, Pfizer and Moderna, last week reported preliminary results from late-stage trials showing that their COVID-19 vaccines were almost 95% effective.
« Back to LIVE

TOP STORIES